Some patients tolerate fat better on the medication than off it
The exact mechanisms through which activation of THR improves MASH are still unclear but are known to control fat synthesis, regulate fatty acid oxidation, regulate cholesterol metabolism, improve mitochondrial function, and reduce inflammation and fibrosis
Half-life supports once-monthly (Q4W) or twice-monthly (Q2W) administration
doi: 10.3390/cancers17193165
Its compounding-pathway status is unsettled: ibutamoren mesylate was nominated for inclusion on FDA's Section 503A bulk drug substances list, and the Pharmacy Compounding Advisory Committee reviewed the nomination at its October 29, 2024 meeting and voted against recommending it for the list, citing concerns about the strength of the safety and efficacy evidence
Suggested Use / Directions: As a dietary supplement, 1 tablet daily on an empty stomach, or as directed by a healthcare professional